192 related articles for article (PubMed ID: 8882031)
1. Outpatient monthly oral bolus cyclophosphamide therapy in systemic lupus erythematosus.
Dawisha SM; Yarboro CH; Vaughan EM; Austin HA; Balow JE; Klippel JH
J Rheumatol; 1996 Feb; 23(2):273-8. PubMed ID: 8882031
[TBL] [Abstract][Full Text] [Related]
2. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of combination treatment with fludarabine and low-dose pulse cyclophosphamide in patients with lupus nephritis.
Illei GG; Yarboro CH; Kuroiwa T; Schlimgen R; Austin HA; Tisdale JF; Chitkara P; Fleisher T; Klippel JH; Balow JE; Boumpas DT
Rheumatology (Oxford); 2007 Jun; 46(6):952-6. PubMed ID: 17317716
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of acute systemic lupus erythematosus with intravenous infusions of cyclophosphamide. Value and limitations].
De Bandt M; Goycochea MV; Meyer O; Delahousse M; Palazzo E; M'Bappé P; Kahn MF
Ann Med Interne (Paris); 1994; 145(2):75-87. PubMed ID: 8024184
[TBL] [Abstract][Full Text] [Related]
5. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
Petri M; Jones RJ; Brodsky RA
Arthritis Rheum; 2003 Jan; 48(1):166-73. PubMed ID: 12528116
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
9. [Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus].
Anić B; Crkvencić N; Mayer M; Bosnić D; Sentić M; Markeljević J; Cikes N
Lijec Vjesn; 1999; 121(9-10):283-8. PubMed ID: 19658369
[TBL] [Abstract][Full Text] [Related]
10. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
Morović-Vergles J; Galesić K; Dancuo I; Vergles D
Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
[TBL] [Abstract][Full Text] [Related]
11. [Intensified therapy of severe lupus erythematosus].
Euler HH; Schröder JO; Gutschmidt HJ; Harten P; Stueber F; Zeuner RA; Löffler H
Dtsch Med Wochenschr; 1991 Jul; 116(28-29):1081-8. PubMed ID: 2065594
[TBL] [Abstract][Full Text] [Related]
12. [Synchronizing therapy with plasmapheresis and cyclophosphamide in rapidly progressing systemic lupus erythematosis with kidney involvement].
Demin AA; Sentiakova TN; Smirnov VV; Demina LM; Mamin IV
Ter Arkh; 1996; 68(5):27-30. PubMed ID: 9082593
[TBL] [Abstract][Full Text] [Related]
13. Crossroads of the effects of cyclophosphamide pulse therapy for lupus nephritis--experience of 11 cases.
Funauchi M; Ikoma S; Sugiyama M; Yu H; Ohno M; Kinoshita K; Hamada K; Kanamaru A
J Clin Lab Immunol; 1998; 50(2):45-54. PubMed ID: 10470622
[TBL] [Abstract][Full Text] [Related]
14. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
Szeto CC; Kwan BC; Lai FM; Tam LS; Li EK; Chow KM; Gang W; Li PK
Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
[TBL] [Abstract][Full Text] [Related]
15. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus.
Marks SD; Patey S; Brogan PA; Hasson N; Pilkington C; Woo P; Tullus K
Arthritis Rheum; 2005 Oct; 52(10):3168-74. PubMed ID: 16200620
[TBL] [Abstract][Full Text] [Related]
16. An open study of B lymphocyte depletion in systemic lupus erythematosus.
Leandro MJ; Edwards JC; Cambridge G; Ehrenstein MR; Isenberg DA
Arthritis Rheum; 2002 Oct; 46(10):2673-7. PubMed ID: 12384926
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.
Kahl LE
J Rheumatol; 1994 Jan; 21(1):84-6. PubMed ID: 8151595
[TBL] [Abstract][Full Text] [Related]
18. EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.
Yee CS; Gordon C; Dostal C; Petera P; Dadoniene J; Griffiths B; Rozman B; Isenberg DA; Sturfelt G; Nived O; Turney JH; Venalis A; Adu D; Smolen JS; Emery P
Ann Rheum Dis; 2004 May; 63(5):525-9. PubMed ID: 15082482
[TBL] [Abstract][Full Text] [Related]
19. [Chromosomal aberrations in lymphocytes of patients with systemic lupus erythematosus during cytostatic therapy].
Latipova NS; Aliavi AL
Ter Arkh; 2002; 74(5):35-8. PubMed ID: 12087903
[TBL] [Abstract][Full Text] [Related]
20. [Intravenous cyclophosphamide in lupus nephritis: twenty years reducing dose].
Frutos MA; Martín Gómez A; de Ramón E; Camps MT; Valera A; García I; Fernández Nebro A
Nefrologia; 2007; 27(1):12-22. PubMed ID: 17402875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
